Therapeutic Options for Patients who are not Eligible for Intensive Chemotherapy
Although “less intense” therapies are finding more use in AML, the principal problem in AML remains lack of efficacy rather than toxicity. Hence less intense therapies are of little use if they are not more effective as well as less toxic than standard therapies. Assignment of patients to less inten...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Università Cattolica del Sacro Cuore
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736881/ |